ID

19702

Description

Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00386087

Link

https://clinicaltrials.gov/show/NCT00386087

Keywords

  1. 1/23/17 1/23/17 -
Uploaded on

January 23, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Neoplasms NCT00386087

Eligibility Breast Neoplasms NCT00386087

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical diagnosis of metastatic breast cancer or recurrent breast cancer where surgery can not be done for curative intent
Description

Secondary malignant neoplasm of female breast Inoperable Curative | Breast cancer recurrent Inoperable Curative

Data type

boolean

Alias
UMLS CUI [1,1]
C0346993
UMLS CUI [1,2]
C0205187
UMLS CUI [1,3]
C1276305
UMLS CUI [2,1]
C0278493
UMLS CUI [2,2]
C0205187
UMLS CUI [2,3]
C1276305
have received prior therapy with an anthracycline (class of drugs) and a taxane (class of drugs).
Description

Anthracyclines Class of Trial Agent | taxane Class of Trial Agent

Data type

boolean

Alias
UMLS CUI [1,1]
C0282564
UMLS CUI [1,2]
C2983595
UMLS CUI [2,1]
C0215136
UMLS CUI [2,2]
C2983595
tumors must not be positive for her2, but if positive, the treatment plan should not include further treatment with the drug herceptin.
Description

HER2-positive carcinoma of breast Herceptin Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C1960398
UMLS CUI [1,2]
C0338204
UMLS CUI [1,3]
C2828389
disease that can be definitely measured on cat scans or other radiological tests.
Description

Measurable Disease X-Ray Computed Tomography | Radiology test

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0040405
UMLS CUI [2]
C0807679
may have received high dose chemotherapy for autologous stem cell support greater than or equal to 6 months of starting this study.
Description

High-Dose Chemotherapy with Autologous Stem Cell Transplant

Data type

boolean

Alias
UMLS CUI [1]
C1512429
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than 2 chemotherapy regimens for metastatic or locally recurrent disease.
Description

Chemotherapy Regimen Quantity Neoplasm Metastasis | Chemotherapy Regimen Quantity Recurrent disease Local

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0277556
UMLS CUI [2,4]
C0205276
have brain cancer from breast cancer
Description

Malignant neoplasm of brain Due to Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0153633
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0678222
pregnant or breastfeeding
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
have an inability to swallow tablets
Description

Able to swallow Tablets

Data type

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0039225
within 6 months have had a serious heart condition
Description

Heart condition Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C3842523
UMLS CUI [1,2]
C0205404

Similar models

Eligibility Breast Neoplasms NCT00386087

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Secondary malignant neoplasm of female breast Inoperable Curative | Breast cancer recurrent Inoperable Curative
Item
clinical diagnosis of metastatic breast cancer or recurrent breast cancer where surgery can not be done for curative intent
boolean
C0346993 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
C0278493 (UMLS CUI [2,1])
C0205187 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
Anthracyclines Class of Trial Agent | taxane Class of Trial Agent
Item
have received prior therapy with an anthracycline (class of drugs) and a taxane (class of drugs).
boolean
C0282564 (UMLS CUI [1,1])
C2983595 (UMLS CUI [1,2])
C0215136 (UMLS CUI [2,1])
C2983595 (UMLS CUI [2,2])
HER2-positive carcinoma of breast Herceptin Excluded
Item
tumors must not be positive for her2, but if positive, the treatment plan should not include further treatment with the drug herceptin.
boolean
C1960398 (UMLS CUI [1,1])
C0338204 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
Measurable Disease X-Ray Computed Tomography | Radiology test
Item
disease that can be definitely measured on cat scans or other radiological tests.
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C0807679 (UMLS CUI [2])
High-Dose Chemotherapy with Autologous Stem Cell Transplant
Item
may have received high dose chemotherapy for autologous stem cell support greater than or equal to 6 months of starting this study.
boolean
C1512429 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Regimen Quantity Neoplasm Metastasis | Chemotherapy Regimen Quantity Recurrent disease Local
Item
more than 2 chemotherapy regimens for metastatic or locally recurrent disease.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
C0205276 (UMLS CUI [2,4])
Malignant neoplasm of brain Due to Breast Carcinoma
Item
have brain cancer from breast cancer
boolean
C0153633 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Able to swallow Tablets
Item
have an inability to swallow tablets
boolean
C2712086 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
Heart condition Serious
Item
within 6 months have had a serious heart condition
boolean
C3842523 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial